Obesity care startup Ilant Health raises $15M Series A for AI‑supported precision‑obesity‑care platform

Ilant Health, a women‑led, value‑based obesity and cardiometabolic care startup based in New York City, has raised $15 million in a Series A funding round to expand its AI‑supported precision‑obesity‑care platform for employers and health plans.

The Series A round was led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, plus existing investors Celtic, LifeX, and AlphaLab; the raise brings Ilant’s total funding to more than $22 million.

Ilant’s platform provides an integrated, single‑front‑door solution for obesity and related metabolic conditions, combining bariatric surgery, GLP‑1 medications (including direct contracts with Eli Lilly and Novo Nordisk), and intensive behavioral therapy within a value‑based, clinician‑led care model.

Early clinical data show Ilant members achieving an average 15% body‑weight loss over one year, compared to a 5.8% benchmark in uncalibrated real‑world settings, along with reported gains of about two additional mentally healthy days per month, helping employers and payers reduce total cost of care.